US Stock MarketDetailed Quotes

Pliant Therapeutics (PLRX)

Watchlist
  • 1.290
  • +0.010+0.78%
Trading Jan 16 15:52 ET
79.27MMarket Cap-0.45P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pliant Therapeutics (PLRX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
34.68%-21.08M
10.36%-40.6M
-61.42%-48.86M
-33.64%-155.5M
-89.87%-47.66M
10.91%-32.27M
-82.95%-45.3M
0.02%-30.27M
-22.96%-116.36M
19.65%-25.1M
Net income from continuing operations
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
Depreciation and amortization
-18.05%436K
-28.14%447K
-12.67%448K
15.43%2.13M
-1.29%458K
18.75%532K
30.40%622K
13.50%513K
0.99%1.84M
1.98%464K
Other non cash items
1.48%821K
-29.13%815K
19.38%813K
44.39%3.45M
45.60%811K
35.51%809K
83.41%1.15M
11.82%681K
28.63%2.39M
-6.86%557K
Change In working capital
-119.27%-2.75M
-304.21%-6.92M
-189.46%-4.23M
626.54%9.09M
-1,443.35%-8.18M
683.74%14.25M
-127.56%-1.71M
251.31%4.73M
-70.33%1.25M
109.30%609K
-Change in receivables
----
----
----
--0
--0
--0
--0
--0
13,120.00%1.98M
--0
-Change in prepaid assets
-85.62%780K
128.38%975K
-73.46%995K
226.29%4.72M
-572.37%-1.02M
405.86%5.43M
-157.76%-3.44M
887.61%3.75M
-1,170.41%-3.74M
94.76%-152K
-Change in payables and accrued expense
-132.92%-2.93M
-492.78%-8.06M
-482.03%-5.15M
-8.96%5.24M
-477.23%-7.06M
557.09%8.9M
-68.48%2.05M
297.51%1.35M
-12.25%5.75M
192.81%1.87M
-Change in other current assets
--0
177.78%35K
--8K
---43K
97.82%-8K
-97.28%10K
---45K
--0
--0
-52.92%-367K
-Change in other current liabilities
-629.27%-598K
144.68%126K
74.93%-91K
70.15%-820K
87.48%-93K
87.72%-82K
58.53%-282K
44.66%-363K
-21.66%-2.75M
16.42%-743K
Cash from discontinued investing activities
Operating cash flow
34.68%-21.08M
10.36%-40.6M
-61.42%-48.86M
-33.64%-155.5M
-89.87%-47.66M
10.91%-32.27M
-82.95%-45.3M
0.02%-30.27M
-22.96%-116.36M
19.65%-25.1M
Investing cash flow
Cash flow from continuing investing activities
-9.82%27.92M
231.59%35.49M
16.07%69.11M
210.49%140.34M
22.59%39.13M
-19.07%30.96M
146.57%10.7M
134.18%59.55M
15.44%-127.01M
59.43%31.92M
Net PPE purchase and sale
117.41%156K
91.05%-112K
82.44%-262K
-317.81%-3.85M
-242.62%-209K
-853.19%-896K
-107.46%-1.25M
-815.34%-1.49M
47.67%-921K
63.25%-61K
Net investment purchase and sale
-12.84%27.77M
197.82%35.6M
13.66%69.38M
214.35%144.19M
23.01%39.34M
-16.93%31.86M
153.42%11.95M
135.07%61.04M
15.06%-126.09M
58.42%31.98M
Cash from discontinued investing activities
Investing cash flow
-9.82%27.92M
231.59%35.49M
16.07%69.11M
210.49%140.34M
22.59%39.13M
-19.07%30.96M
146.57%10.7M
134.18%59.55M
15.44%-127.01M
59.43%31.92M
Financing cash flow
Cash flow from continuing financing activities
-86.74%72K
0
-97.71%498K
-91.58%23.12M
-53.42%102K
-22.32%543K
324.84%684K
-92.03%21.79M
20.96%274.41M
-22.89%219K
Net issuance payments of debt
--0
--0
--0
--19.91M
--1K
--0
--0
--19.91M
--0
--0
Net common stock issuance
----
----
----
-98.83%3.21M
-56.47%101K
-29.84%543K
-35.84%2.56M
--0
26.52%275.25M
321.82%232K
Proceeds from stock option exercised by employees
----
--0
-73.50%498K
----
----
----
--684K
-48.68%1.88M
----
----
Net other financing activities
----
----
----
----
----
----
----
----
-52.06%-847K
-103.43%-13K
Cash from discontinued financing activities
Financing cash flow
-86.74%72K
--0
-97.71%498K
-91.58%23.12M
-53.42%102K
-22.32%543K
324.84%684K
-92.03%21.79M
20.96%274.41M
-22.89%219K
Net cash flow
Beginning cash position
7.86%88.3M
-19.31%93.42M
12.29%72.67M
92.13%64.72M
40.60%81.1M
48.98%81.87M
12.93%115.78M
92.12%64.72M
-34.80%33.68M
29.28%57.68M
Current changes in cash
997.66%6.91M
84.91%-5.12M
-59.37%20.75M
-74.37%7.95M
-219.75%-8.43M
-128.23%-770K
28.72%-33.91M
-25.83%51.06M
272.58%31.03M
164.37%7.04M
End cash Position
17.41%95.21M
7.86%88.3M
-19.31%93.42M
12.29%72.67M
12.29%72.67M
40.60%81.1M
48.98%81.87M
12.93%115.78M
92.13%64.72M
92.13%64.72M
Free cash flow
36.44%-21.08M
12.53%-40.72M
-54.66%-49.13M
-35.87%-159.35M
-90.24%-47.87M
8.67%-33.17M
-83.53%-46.55M
-4.35%-31.76M
-21.67%-117.28M
19.88%-25.16M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 34.68%-21.08M10.36%-40.6M-61.42%-48.86M-33.64%-155.5M-89.87%-47.66M10.91%-32.27M-82.95%-45.3M0.02%-30.27M-22.96%-116.36M19.65%-25.1M
Net income from continuing operations 54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M
Depreciation and amortization -18.05%436K-28.14%447K-12.67%448K15.43%2.13M-1.29%458K18.75%532K30.40%622K13.50%513K0.99%1.84M1.98%464K
Other non cash items 1.48%821K-29.13%815K19.38%813K44.39%3.45M45.60%811K35.51%809K83.41%1.15M11.82%681K28.63%2.39M-6.86%557K
Change In working capital -119.27%-2.75M-304.21%-6.92M-189.46%-4.23M626.54%9.09M-1,443.35%-8.18M683.74%14.25M-127.56%-1.71M251.31%4.73M-70.33%1.25M109.30%609K
-Change in receivables --------------0--0--0--0--013,120.00%1.98M--0
-Change in prepaid assets -85.62%780K128.38%975K-73.46%995K226.29%4.72M-572.37%-1.02M405.86%5.43M-157.76%-3.44M887.61%3.75M-1,170.41%-3.74M94.76%-152K
-Change in payables and accrued expense -132.92%-2.93M-492.78%-8.06M-482.03%-5.15M-8.96%5.24M-477.23%-7.06M557.09%8.9M-68.48%2.05M297.51%1.35M-12.25%5.75M192.81%1.87M
-Change in other current assets --0177.78%35K--8K---43K97.82%-8K-97.28%10K---45K--0--0-52.92%-367K
-Change in other current liabilities -629.27%-598K144.68%126K74.93%-91K70.15%-820K87.48%-93K87.72%-82K58.53%-282K44.66%-363K-21.66%-2.75M16.42%-743K
Cash from discontinued investing activities
Operating cash flow 34.68%-21.08M10.36%-40.6M-61.42%-48.86M-33.64%-155.5M-89.87%-47.66M10.91%-32.27M-82.95%-45.3M0.02%-30.27M-22.96%-116.36M19.65%-25.1M
Investing cash flow
Cash flow from continuing investing activities -9.82%27.92M231.59%35.49M16.07%69.11M210.49%140.34M22.59%39.13M-19.07%30.96M146.57%10.7M134.18%59.55M15.44%-127.01M59.43%31.92M
Net PPE purchase and sale 117.41%156K91.05%-112K82.44%-262K-317.81%-3.85M-242.62%-209K-853.19%-896K-107.46%-1.25M-815.34%-1.49M47.67%-921K63.25%-61K
Net investment purchase and sale -12.84%27.77M197.82%35.6M13.66%69.38M214.35%144.19M23.01%39.34M-16.93%31.86M153.42%11.95M135.07%61.04M15.06%-126.09M58.42%31.98M
Cash from discontinued investing activities
Investing cash flow -9.82%27.92M231.59%35.49M16.07%69.11M210.49%140.34M22.59%39.13M-19.07%30.96M146.57%10.7M134.18%59.55M15.44%-127.01M59.43%31.92M
Financing cash flow
Cash flow from continuing financing activities -86.74%72K0-97.71%498K-91.58%23.12M-53.42%102K-22.32%543K324.84%684K-92.03%21.79M20.96%274.41M-22.89%219K
Net issuance payments of debt --0--0--0--19.91M--1K--0--0--19.91M--0--0
Net common stock issuance -------------98.83%3.21M-56.47%101K-29.84%543K-35.84%2.56M--026.52%275.25M321.82%232K
Proceeds from stock option exercised by employees ------0-73.50%498K--------------684K-48.68%1.88M--------
Net other financing activities ---------------------------------52.06%-847K-103.43%-13K
Cash from discontinued financing activities
Financing cash flow -86.74%72K--0-97.71%498K-91.58%23.12M-53.42%102K-22.32%543K324.84%684K-92.03%21.79M20.96%274.41M-22.89%219K
Net cash flow
Beginning cash position 7.86%88.3M-19.31%93.42M12.29%72.67M92.13%64.72M40.60%81.1M48.98%81.87M12.93%115.78M92.12%64.72M-34.80%33.68M29.28%57.68M
Current changes in cash 997.66%6.91M84.91%-5.12M-59.37%20.75M-74.37%7.95M-219.75%-8.43M-128.23%-770K28.72%-33.91M-25.83%51.06M272.58%31.03M164.37%7.04M
End cash Position 17.41%95.21M7.86%88.3M-19.31%93.42M12.29%72.67M12.29%72.67M40.60%81.1M48.98%81.87M12.93%115.78M92.13%64.72M92.13%64.72M
Free cash flow 36.44%-21.08M12.53%-40.72M-54.66%-49.13M-35.87%-159.35M-90.24%-47.87M8.67%-33.17M-83.53%-46.55M-4.35%-31.76M-21.67%-117.28M19.88%-25.16M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.60%
Sample Name
Sample Code
 +2.46%
Sample Name
Sample Code
 +2.18%
4
Tempus AI
TEM
+1.97%
5
Block
XYZ
+1.57%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.40%
Sample Name
Sample Code
 +10.23%
Sample Name
Sample Code
 +10.07%
4
Kingsoft Cloud
KC
+8.08%
5
United Microelectronics
UMC
+5.97%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -